Pablo Pelegrin

Pablo Pelegrin

Company: Biomedical Research Institute of Murcia University of Murcia

Job title: Scientific Deputy Director


Use of NLRP3 Inflammasome Activity as a Disease Biomarker for Patient Stratification & the Design of Clinical Trials Testing NLRP3 Antagonists 2:30 pm

NLRP3 inflammasome response is able to early stratify septic patients gravity A group of septic patients present a profound NLRP3 immunosuppression associated with their gravity NLRP3 activity is as a biomarker to stratify patients and design clinical trialsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.